We investigated the effect of ischemia and reperfusion on the cardiac ryanodine receptor, which corresponds to the sarcoplasmic reticulum Ca2+ channel. Isolated working rat hearts were subjected to 10 to 30 minutes of global ischemia, followed or not by reperfusion. Ischemia produced significant reduction in the density of high-affinity 3H-ryanodine binding sites, determined either in whole-heart homogenate (Bmax7 220+22, 203+ 12, and 228±14 fmol/mg protein after 10, 20, and 30 minutes of ischemia versus 298±18 fmol/mg protein in the control condition; P<.01) or in a fraction enriched in sarcoplasmic reticulum (Bmax, 1.08±0.15 pmol/mg protein after 20 minutes of ischemia versus 1.69±0.08 pmol/mg protein in the control condition; P<.01).
268 nm, using an extinction coefficient of 1.45x 104 (mol/L)-1.
Such an extinction coefficient was calculated by the manufacturer for the specific lot of ryanodine used in these experiments, and its accuracy was confirmed by determining the absorbance of a stock solution. EGTA was obtained from Sigma Chemical Co, St Louis, Mo, and its alleged purity was 97%. All other reagents were of analytical grade.
Free-Ca 2+ concentration was calculated according to Fabiato and Fabiato,16 using a computer program that included an empirical correction for the ionic strength of the buffer. The pH of each solution containing Ca2' and EGTA was carefully adjusted. Free Ca 2+ was also evaluated with the arsenazo III technique'7 in the standard binding buffer and in the buffer used for Ca2+-uptake experiments (see below), and the results were in good agreement (+ 10%) with the theoretical values.
'H-Ryanodine and 45CaCI2 were obtained from New England Nuclear-DuPont, Milan, Italy, and diluted to the desired specific activity, respectively, with cold ryanodine and with a stock solution of CaCl2 purchased from BDH, Poole, UK.
Animals and Perfusion Technique
Sprague-Dawley rats, fed with standard diet (275 to 300 g body weight), were anesthetized with a mixture of ether and air. After injection of 1000 U sodium heparin in the femoral vein, the heart was quickly excised and perfused according to the working heart technique. 18 The preload (height of the atrial chamber) and the afterload (height of the aortic chamber) were set at 20 and 70 cm, respectively. Aortic flow and coronary flow were measured by collecting the overflow from the aortic chamber and the effluent from the heart chamber into graduated cylinders. Aortic pressure was monitored by a membrane transducer (P23 ID, Gould, Oxnard, Calif) connected to a side arm of the aortic cannula. Heart rate was calculated from aortic pressure tracings that were recorded on paper every 5 minutes. Cardiac output was determined as the sum of aortic and coronary flow, and minute work was determined as the product of cardiac output and peak systolic aortic pressure. The release of LDH in the perfusion buffer was measured according to Bergmeyer and Bernt.19 Krebs-Henseleit bicarbonate buffer was the standard perfusion medium. Its composition was as follows (mmol/L): NaCl 118, NaHCO3 25, KCl 4.5, KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5, and glucose 11. The buffer was recirculated and equilibrated with a mixture of oxygen (95%) and carbon dioxide (5%). Temperature was kept between 37C and 37.4°C, and pH was 7.4.
Control hearts were perfused aerobically for 30 minutes. Ischemic hearts were subjected to 10 minutes of aerobic perfusion followed by 10 to 30 minutes of global normothermic ischemia, obtained by the occlusion of the aortic and atrial cannulas. Reperfused hearts underwent 10 minutes of aerobic perfusion, 10 to 30 minutes of global ischemia, and 10 minutes of retrograde reperfusion (aortic pressure, 80 mm Hg) followed, if contractile activity was restored, by 10 minutes of working heart reperfusion.
Preparation of Cellular Fractions
At the end of the perfusion, the hearts were quickly removed from the perfusion apparatus and washed in isotonic saline. The ventricles were separated from the atria and great vessels, finely minced, and homogenized in 5 vol of 300 mmol/L sucrose and 10 mmol/L imidazole (pH 7.0 at 4°C). Unless otherwise specified, homogenization was performed by 15+15 passes in a Potter-Elvejheim homogenizer set at 800 rpm and kept in a cold room at 4°C. In some experiments, homogenization was carried out through a device containing rotating blades (Ultraturrax, Janke & Kunkel, Staufen, Germany) that was set at two thirds of maximum speed for 10 seconds + 10 seconds; in other experiments, protease inhibitors were added to the homogenization buffer (see below).
The homogenate was filtered through one layer of cheesecloth; a portion (1 mL) was taken for the assay of Ca2`uptake and 'H-ryanodine binding; the rest was centrifuged at 800g for 10 minutes, obtaining two fractions, which are usually referred to as "postnuclear supernatant" (PNS) and "nuclear pellet" (NP).20,21 The NP was resuspended in homogenization buffer. The PNS and NP were further characterized by determining their LDH,19 cytochrome c oxidase, Ca2+-ATPase, and K+(EDTA)-ATPase activities. LDH is a cytosolic enzyme; cytochrome c oxidase is a mitochondrial marker; Ca2+-ATPase activity is influenced by several enzymes, the chief being the myosin ATPase and the SR Ca21 pump; and K+(EDTA)-ATPase activity is a relatively specific marker of myosin.22 Cytochrome c oxidase was assayed according to Storrie and Madden.23 ATPase activity was determined by measuring inorganic phosphate production. 24 The reaction medium used for the assay of Ca2+-ATPase contained 10 mmol/L imidazole (pH 7.1), 100 mmol/L KCl, 2 mmol/L MgCl2, 2.5 mmol/L K3-ATP, and 2 ,umol/L A23187; Ca2+-dependent ATPase was defined as ATPase activity in the presence of 100 ,mol/L CaCl2 minus ATPase activity in the presence of 2 mmol/L EGTA. K+(EDTA)-ATPase was assayed according to Pollard. 22 In addition, a rough quantitative evaluation of heavy myosin distribution was performed after polyacrylamide gel electrophoresis, as described by Fenner et al. 25 Although filtering the crude homogenate is a procedure that is commonly used to remove fragments of tissue that have not been disrupted, it seems necessary to ascertain that the filtered homogenate is still representative of the whole tissue. To this purpose, in some hearts (three control hearts and three hearts subjected to 20 minutes of ischemia) ryanodine binding and oxalate-supported Ca 2+ uptake were determined as detailed below both in the crude and in the filtered homogenate. The filtered homogenate contained 85+±2% of total proteins, and the results of the assays, if expressed per milligram of protein, were not affected by cheesecloth filtration: in the filtered homogenate, the B,,,. for ryanodine binding, basal Ca21 uptake, and ryanodine-stimulated Ca21 uptake averaged 95 ±3%, 96+8%, and 108+6%, respectively, of the values obtained in the crude homogenate, and these ratios were virtually identical in control and ischemic hearts.
In some experiments, the PNS was used to prepare a microsomal fraction enriched in SR, according to the procedure described by Harigaya and Schwartz,26 with minor modifications. The PNS was centrifuged at 8700g for 20 minutes. The resulting supernatant was recentrifuged at 8700g for 20 minutes, yielding another supernatant fraction, which was centrifuged at 40 OOOg for 30 minutes. The precipitate was resuspended in a glass homogenizer with 5 vol of 600 mmol/L KCl and 10 mmol/L imidazole (pH 7.0 at 4'C). This suspension was centrifuged at 40 O(Kg for 25 minutes to remove solubilized actomyosin, and the precipitate, representing the microsomal fraction enriched in SR, was resuspended in homogenization buffer.
Each preparation was obtained from one heart, except for the fraction enriched in SR, which was obtained from pooled homogenates derived from three or four hearts, all subjected to the same perfusion protocol. All centrifugations were performed at 4'C. The protein content of each fraction was determined by the Lowry method,27 using bovine serum albumin as a standard.
Assay of 3H-Ryanodine Binding
High-affinity ryanodine binding was determined as described by Holmberg and Williams,28 with minor changes.
Unless otherwise specified, membranes (protein concentration, 0.6 to 1.0 mg/mL for crude preparations and 0.1 to 0.3 mg/mL for the fraction enriched in SR) were incubated at 37'C for 60 minutes in a buffered medium (final volume, 1 mL) containing 25 mmol/L imidazole (pH 7.4 at 37°C), 1 mol/L KCI, 0.2 to 50 nmol/L 3H-ryanodine (6 Ci/mmol), 0.950 Average values calculated over 30 minutes of aerobic perfusion are reported for control hearts; during this period, hemodynamic performance was stable. In the reperfused groups, hemodynamic variables were measured after 10 minutes of retrograde (Langendorff) reperfusion followed by 10 minutes of working heart reperfusion. Data shown for the 20-minute group were derived from the hearts that recovered sinus rhythm after the first 10 minutes of reperfusion (see text for further details). All the hearts subjected to 30 minutes of ischemia developed irreversible ventricular fibrillation during reperfusion, and coronary flow was measured during retrograde reperfusion.
*P<.05, tP<.01 vs control condition (0 minutes), as assessed by ANOVA. mmol/L EGTA, and 1.013 mmol/L CaCl2. Binding was usually determined using six concentrations of the ligand, which we found to be sufficient for an accurate estimate of the binding parameters. Free-Ca 2+ concentration was 20 ,mol/L. In some experiments, CaCl2 concentration was adjusted to obtain free-Ca21 concentrations ranging from 0.1 ,umol/L to 1 mmol/L; in others, KCl concentration was reduced to 150 mmol/L.
The binding reaction was terminated by filtration through cellulose nitrate filters with pores of 0.45 ,um (Sartorius, Gottingen, Germany) presoaked in 25 mmol/L imidazole (pH 7.4) and 1 mol/L KCl (washing buffer). The filters were washed with 2x5-mL aliquots of washing buffer and shaken overnight in 8 mL scintillation fluid (Optiphase II, LKB). Radioactivity was then measured at 50% efficiency in an LKB Wallac 1214 scintillation counter. Each vial was counted for 10 minutes. Incubations were performed in duplicate, and nonspecific binding was determined in the presence of 10 ,umol/L ryanodine. The difference between the counts of duplicate samples was <10% in all cases.
To assess low-affinity ryanodine binding, 3H-ryanodine was used at concentrations ranging from 0.4 to 20 ,lmol/L (120 Ci/mol), and nonspecific binding was determined in the presence of 2.5 mmol/L ryanodine. Filters were washed with 2x5-mL aliquots of washing buffer and 5 mL of 10% (wt/vol) ethanol. Careful analysis of filter binding in the absence of added membranes was performed at each concentration of 3H-ryanodine. Since we observed that filter-bound 3H-ryanodine was partly displaced by unlabeled ryanodine, specific binding was calculated as follows: (3H-ryanodine bound in the presence of membranes minus 3H-ryanodine bound in the presence of membranes and 2.5 mmol/L unlabeled ryanodine) minus (3H-ryanodine bound in the absence of membranes minus 3H-ryanodine bound in the absence of membranes and in the presence of 2.5 mmol/L unlabeled ryanodine).
Several issues of the methodology used to determine 3Hryanodine binding were validated through preliminary experiments:
Use of Protease Inhibitors
In some experiments (two control hearts and two hearts subjected to 20 minutes of ischemia), tissue homogenization and 3H-ryanodine binding were performed in the presence of protease inhibitors. After tissue mincing, the material was divided into two parts: one was processed as described above; the other was homogenized in the presence of S ,umol/L leupeptin, 2 ,umol/L pepstatin, 0.25 gmol/L aprotinin, 200 ,umol/L phenylmethylsulfonyl fluoride, 2 mmol/L iodoacetamide, and 2 mmol/L benzamide, which were also added to the binding buffer. The presence of such inhibitors did not modify 3H-ryanodine binding (the Bma, averaged 102±-6% of the value obtained in the absence of inhibitors), and this finding provided the rationale for omitting protease inhibitors in the other experiments.
Incubation Time
Analysis of 3H-ryanodine association showed that 60 minutes of incubation was sufficient to reach equilibrium.
Type of Filters Used
3H-Ryanodine binding to cellulose nitrate filters was a serious problem when determining low-affinity binding. In pilot experiments, the use of cellulose acetate (Sartorius) or glass fiber filters (Whatman GF/B and GF/C, Maidstone, UK) was tested, but filter binding was similar or even higher. In additional experiments, binding was terminated by centrifugation, but no improvement in the ratio of specific to total binding was obtained.
Assay of Ca2' Uptake
The rate of oxalate-supported Ca2+ uptake was measured as described elsewhere,8 with minor changes. Membranes (protein concentration, 0.5 to 0.8 mg/mL) were preincubated at 37°C for 5 minutes in the presence or absence of 900 ,umol/L ryanodine. Preliminary experiments (see below) showed that this concentration produced maximum stimulation of Ca2l uptake. The uptake medium (final volume, 0.5 mL) contained the following final concentrations (mmol/L): imidazole 40 (pH 7.0 at 37°C), KCl 100, sucrose 60, NaN3 8, MgCl2 3, EGTA 0.145, 45CaC12 0.4 (0.2 ,lCi/mL), potassium oxalate 10, and K3-ATP 5, along with 810 ,umol/L ryanodine where appropriate. Free-Ca21 concentration was 33 ,umol/L. The uptake reaction was started by the addition of K3-ATP and potassium oxalate to the other reagents. Aliquots (100 ,L) were taken at 15-second intervals and filtered by suction under vacuum through cellulose nitrate filters with pores of 0.45 ptm (Sartorius), which were quickly washed with 2x2-mL aliquots of washing buffer (mmol/L: imidazole 40, KCl 100, NaN3 8, MgCl2 3, and EGTA 0.2). Filtration and washing took -5 seconds. The radioactivity associated with the filters was measured by scintillation counting (LKB Wallac 1214), and the uptake rate was calculated by linear regression analysis of the first 60 seconds. Ca 2+ uptake was determined in duplicate immediately after tissue homogenization or, when PNS and NP were used, as soon as these fractions were prepared.
Statistical Analysis
Results are expressed as mean+SEM. Binding data were analyzed through the SCAFIT (LIGAND) program. 29 Differences between groups were evaluated by ANOVA: Fisher's F test was first used to compare between-group variance and withingroup variance; if the former was significantly (P<.05) higher 
Results

Hemodynamic Performance
The hemodynamic variables measured in the different groups are shown in Table 1 . In each case, ischemia produced complete arrest of contractile activity within a few minutes. Reperfusion after 10 minutes of ischemia was associated with moderate impairment in mechanical performance, eg, 15% to 20% decrease in cardiac output and minute work, without any leakage of intracellular enzymes, providing a model of "stunned" myocardium. When ischemic time was increased to 20 minutes, appreciable LDH leakage was observed after reperfusion, contractile impairment was more severe, and serious reperfusion arrhythmias (ventricular tachicardia or fibrillation) occurred in 50% of the hearts (three of six). Since the occurrence of arrhythmias was not associated with apparent differences in 3H-ryanodine binding or 45Ca21 uptake, in the subsequent sections the results obtained in all the hearts of this group are pooled together. This does not exclude with certainty the existence of a correlation between reperfusion arrhythmias and SR function: the number of the experiments was too small to reach a conclusion on this question, which is beyond the scope of the present study. Thirty minutes of ischemia produced extensive cellular injury and no recovery of contractile activity after reperfusion.
Assay of 3H-Ryanodine Binding
Examples of 3H-ryanodine binding curves obtained at pCa 4.7 (20 ,mol/L free Ca21) in the high-affinity range are shown in Figs 1 and 2. Specific binding was >85% of total binding at 1.5 nmol/L 3H-ryanodine, and approximately two thirds of nonspecific binding was due to filter binding; filter-bound radioactivity was not displaced by FIG in the supernatant after centrifugation at 800g for 10 minutes. The SR fraction, which derived from the PNS through further purification steps, contained "'20% of overall 3H-ryanodine binding. Similar results were obtained if homogenization was performed through rotating blades (Ultraturrax), with the only difference being that the fraction of ryanodine receptors released in the PNS was lower, "'20% versus 45%. Therefore, in all subsequent experiments, hearts were homogenized by Teflon pestle (Potter-Elvejhem).
Ischemia produced significant reduction in the density of 3H-ryanodine binding sites. In whole-heart homogenate, the B,,,,, decreased by 25% to 30% (see were "'600 to 4000 cpm. Each preparation was obtained from three hearts, all subjected to the same perfusion protocol. On the left, saturation binding curves are shown; on the right, Scatchard plots. In each group 3H-ryanodine binding was determined in three to six preparations by using six different 3H-ryanodine concentrations. Protein content was 63±3 mg per ventricle. Since :"15% of the original proteins were lost when the homogenate was filtered on cheesecloth (see "Materials and Methods"), the protein content of the crude homogenate can be estimated to be -75 mg per ventricle or 100 to 110 mg/g ventricular wet weight. The fraction of proteins recovered in the PNS and in the NP was 38±2% and 57±5%, respectively, with the overall yield averaging 96±5%. The yield for 3H-ryanodine binding sites (PNS+NP vs homogenate) was 110±4%. In the SR fraction, the recovery of proteins and 3H-ryanodine binding was 3±1% and 19±2%, respectively. No significant difference between groups was observed for any of these variables.
*P<.01, tP<.05 vs control, as assessed by ANOVA.
and Table 2 ). Such reduction was observed after 10 minutes of ischemia, and longer ischemic times did not produce additional changes. The effect of ischemia concerned only the fraction of receptors released in the PNS, since no change in Bmax was detected in the NP ( Table 2 ). The assay of 3Hryanodine binding in the fraction enriched in SR showed 40% reduction in Bmax after 20 minutes of ischemia (Fig 2) .
Displacement experiments gave similar results in control and ischemic hearts: in the SR fraction 3Hryanodine was displaced by unlabeled ryanodine with Ki values of 1.7+0.2 and 1.4+0.2 nmol/L, respectively (P=NS, data not shown; 3H-ryanodine concentration was 1.45 nmol/L; and ischemic time was 20 minutes).
An important variable affecting high-affinity 3H-ryanodine binding is free-Ca2' concentration.28,3132 As shown in Fig 3, such Ca2' dependence was retained after 20 minutes of ischemia, even if at each Ca 2+ concentration 3H-ryanodine binding was lower than in control hearts. Similar findings were obtained at low ionic strength, ie, under conditions that did not promote optimal binding (Fig 3, right) : although overall binding decreased remarkably, in good agreement with the results reported in the same experimental conditions by Holmberg and Williams,28 clear Ca2+ dependence was present in both control and ischemic tissue.
Twenty minutes of reperfusion produced no substantial recovery in 3H-ryanodine binding. In reperfused hearts, the Bm, was not significantly higher than in the The PNS and the NP were obtained from the homogenate after centrifugation at 800g for 10 minutes. The SR fraction was derived from the PNS through further purification steps. See "Materials and Methods" for further details. Data were obtained from four control hearts and three hearts subjected to 20 minutes of global ischemia. . Binding was determined in postnuclear supernatant, with 4 nmol/L 3H-ryanodine and pCa ranging from 7 to 3. KCI concentration was set at 1 mol/L (left) or 150 mmol/L (right) to assess 3H-ryanodine binding under optimal and suboptimal conditions. pCa corresponding ischemic hearts, whereas the decrease in control hearts was still statistically significant in all cases but one (homogenate of hearts reperfused after 10 minutes of ischemia, in which P=.07).
The analysis of low-affinity 3H-ryanodine binding is technically difficult because of high nonspecific counts. In addition, we observed that the radioactivity bound to filters in the absence of membranes was partly displaced by unlabeled ryanodine.
Because of these technical problems, it was impossible to study low-affinity 3H-ryanodine binding in crude preparations. Satisfactory results were obtained in the fraction enriched in SR. Representative data obtained in control conditions and after 20 minutes of ischemia are shown in Dose-response studies ( Fig 5) showed that maximal low-affinity range. The plots are representative results obtained from control hearts (-) and hearts subjected to 20 minutes of global ischemia (o). In each group, the preparation was derived from four hearts. Data represent specific 3H-ryanodine binding, which was calculated as follows: (3H-ryanodine bound in the presence of membranes minus 3H-ryanodine bound in the presence of membranes and 2.5 mmol/L unlabeled ryanodine) minus (H-ryanodine bound in the absence of membranes minus 3H-ryanodine bound in the absence of membranes and in the presence of 2.5 mmol/L unlabeled ryanodine). See "Materials and Methods" for further details. When 3H-ryanodine was used at concentrations in the micromolar range, specific binding averaged 15% to 20% of total binding,; and filter binding accounted for 40% of total binding. On the left, saturation binding curves are shown; note that several points corresponding to 3H-ryanodine concentrations of <50 nmol/L are not represented for clarity. On the right, Scatchard Graph showing the effect of increasing concentrations of ryanodine on oxalate-supported 45Ca2+ uptake. Data were obtained in unfractionated homogenate derived from one control heart. Membranes were preincubated with ryanodine for 5 minutes before starting the uptake reaction by the addition of ATP and oxalate. Such an addition produced a 10% decrease in actual ryanodine concentration. Preincubation for 10 minutes gave similar results (eg, 30.2 vs 31.6 nmol/min per milligram of protein at 900 ,umol/L ryanodine concentration; data not shown). stimulation occurred with 900 ,umol/L ryanodine, and the ratio of ryanodine-stimulated Ca2+ uptake to basal Ca2+ uptake approached 2. If preincubation was prolonged to 10 minutes, no further increase in Ca2+ uptake was observed. Therefore, in subsequent experiments, the response to ryanodine was assessed after 5 minutes of preincubation at 900 ,umol/L concentration.
After ischemia, oxalate-supported Ca2+ uptake was remarkably reduced (by 19%, 49%, and 61% after 10, 20, and 30 minutes, respectively), but normal or near normal values were restored after reperfusion (Fig 6,  left) .
When Ca2+ uptake was measured in the presence of ryanodine, significant depression was again observed during ischemia (27%, 38%, and 43% after 10, 20, and 30 minutes, respectively), with substantial recovery after reperfusion (Fig 6, right) . During ischemia or ischemia/ reperfusion, the stimulation produced by ryanodine was only slightly reduced, and borderline statistical significance was observed in one ischemic group (Fig 7) .
The distribution of Ca2+ uptake between subcellular fractions was studied in control hearts and in hearts subjected to 20 minutes of ischemia ( Table 4 ). The PNS contained :60% and 50% of ryanodine-insensitive and ryanodine-sensitive Ca 2+-uptake activity, respectively.
The impairment in Ca2+-uptake activity observed after ischemia concerned both the PNS and the NP. However, in ischemic hearts the stimulation of Ca2+ uptake produced by ryanodine was significantly reduced in the PNS, whereas it was substantially unchanged in the NP.
Discussion
In the present study, we investigated the influence of ischemia and reperfusion on ryanodine binding. In whole-heart homogenate, the density of high-affinity ryanodine binding sites was =300 fmol/mg protein, which corresponds to :30 pmol/g ventricular muscle, in good agreement with previous reports.33 Tissue fractioning showed that >50% of the binding sites were retained in the pellet of a low-speed centrifugation. It has been known for years that the NP is quite heterogeneous.20,21 In particular, we observed that in cardiac tissue this fraction included nearly 60% of the cellular proteins, as already outlined in the pioneer study by Cleland and Slater,34 and contained the bulk of the contractile proteins and a large fraction of the cytochrome c oxidase activity. Therefore, it is not surprising that part of the SR was also sedimented by a low-speed centrifugation. It remains to be determined whether this high-density fraction of the SR corresponds to any of its morphological components (eg, junctional versus extended junctional SR35) or to the portions of the SR that are more closely associated with other intracellular structures, such as myofibrils or mitochondria. In any case, our findings support the view that whole-heart homogenate measurements are necessary whenever an estimate of overall SR function is required. '3 Ischemia produced significant reduction in the number of high-affinity ryanodine binding sites, which persisted after reperfusion. The reduction concerned the fraction of receptors released in the PNS, since in the NP ryanodine binding was not affected by ischemia. Ischemia and reperfusion had no major influence on the Ry indicates ryanodine; ARy, stimulation of Ca2+ uptake produced by Ry; PNS, postnuclear supernatant; and NP, nuclear pellet. Values are mean±SEM of five hearts in each group.
Oxalate-supported Ca2+ uptake was measured in the absence of Ry (basal) or after 5 minutes of preincubation with 900 .tmol/L Ry. See "Materials and Methods" for further details. The yield of Ca2+-uptake activity (PNS+NP vs homogenate) in the absence and in the presence of Ry was 103±4% and 89±5%, respectively, without any significant difference between groups.
intrinsic properties of the receptors, such as the Kd and the Ca2' dependence of ryanodine binding.
Crude preparations such as whole-heart homogenate or PNS are contaminated by many extra-SR components, including soluble molecules. However, it is unlikely that ryanodine binding was inhibited by metabolites produced or accumulated during ischemia, because similar results were obtained in the fraction enriched in SR.
Consistent with our results, Darling et a136 have recently reported that, in cardiac SR, ischemia did not affect the Kd for ryanodine or the regulation of Ca2' release by Ca2', Mg 2+, and adenine nucleotide. These authors observed a reduction in the Bm,, for ryanodine after 60 minutes of ischemia but could not conclude that the density of SR channels was affected by ischemia, because their ischemic SR preparation was increasingly contaminated by myofibrillar proteins. In our experimental model, myofibrillar contamination, as estimated by K+(EDTA)-ATPase activity, was not different in SR preparations obtained from control hearts or hearts subjected to 20 minutes of ischemia (see Table 3 ), and this is consistent with the electrophoretic data reported by Darling et al (Fig 4 of Reference 36 ) in which increased staining of myosin (Mr, -205 000) was apparent after 60 minutes but not after 15 minutes of ischemia. Furthermore, the results obtained in crude unfractionated homogenate definitely establish that the reduction of ryanodine binding observed in ischemic tissue was not artifactual.
Ryanodine receptors contain both high-affinity (Kd in the nanomolar range) and low-affinity binding sites. A low-affinity site with Kd in the micromolar range was described in cardiac tissue by several investigators,1,5,6,37 and it is thought that interaction of ryanodine with this site determines channel blockade. Additional sites with intermediate affinity (Kd10-8 to 10-7 mol/L) were also described.6'31'32 These findings were interpreted through the speculation that the complete channel is a homotet-ramer38 containing four negatively cooperative binding sites.6 Conversion of highinto low-affinity sites was reported to occur in skeletal muscle under particular conditions, such as low Ca 2+ concentration or tryptic digestion.39 To investigate whether ischemia might have a similar effect, we tried to determine low-affinity ryanodine binding.
Technical problems, particularly high-filter binding, made it extremely difficult to detect low-affinity ryanodine binding in crude preparations. In the fraction enriched in SR, we identified a low-affinity site with a Kd of 2 ltmol/L, in good agreement with previous reports.1'5'6'3739 No improvement in data fitting was obtained with models including more than two binding sites. However, the existence of additional sites with intermediate affinity6 cannot be excluded on the basis of our findings, since we could determine only a limited number of binding points, which were selected to identify the highest and lowest affinity sites. It has been argued that up to 50 binding points may be necessary for a reliable comparison of two-and three-site models,40 but this was beyond the scope of our investigation. The density of low-affinity ryanodine binding sites was reduced during ischemia, and the ratio of lowto high-affinity sites was unchanged. Although the tetramer model predicts a ratio of 3,38,39 values in the range of 10 to 50 were obtained in the present study as well as by most other investigators, both in heart1'6'37 and in skeletal muscle.5'6 It is not clear whether this discrepancy is due to receptor alteration during tissue homogenization and fractioning or to the limited accuracy of the binding technique.
These questions raise some doubts about the validity of the implications drawn from the analysis of lowaffinity ryanodine binding. However, it seems reasonable to conclude that ischemia does not cause conversion of highinto low-affinity sites but, rather, a reduction in the number of active, ie, ryanodine-binding, receptors. The molecular mechanisms responsible for receptor alteration remain to be determined. Possible mechanisms include changes in redox potential, intracellular acidosis, exposure to reactive oxygen species,41 proteolysis, phosphorylation or dephosphorylation,42'43 and modification of receptor interaction with the SR membrane. Whatever the mechanism may be, it appears to be operating in the early phase of ischemia, before any irreversible cellular injury is produced, since most of the reduction in ryanodine binding occurred in the first 10 minutes of ischemia.
In our experimental model, we also determined the effect of ryanodine on SR Ca21 uptake. The purpose of these studies was to evaluate the functional implication of receptor modifications and to verify the discordant results reported in the literature. 8"13-15 The assay of SR Ca21 uptake, either in the absence or in the presence of ryanodine, showed severe impairment during ischemia, with good recovery after reperfusion. This is in agreement with previous investigations.7-9 The response to ryanodine, ie, the stimulation of Ca21 uptake after preincubation with 900 ,umol/L ryanodine, was much less affected, and significant reduction was observed only in the PNS of the hearts subjected to 20 minutes of ischemia. The results obtained in crude homogenate are consistent with those recently reported by Kaplan et al, 15 who observed a slight (not significant) reduction in the response to ryanodine after 15 minutes of ischemia in the isolated rabbit heart. Davis et al14 reported a slight (not significant) increase in ryanodine-induced stimulation of Ca2' uptake after 5 to 30 minutes of ischemia in the isolated perfused rat heart, but the response to the other channel blocker, ruthenium red, was reduced.14 However, a significant increase in the response to ryanodine after 30 minutes of ischemia was observed in a similar model by Feher et al.13 The reason for these discrepancies remains to be determined and might be related to differences in the homogenization procedure. In particular, in the latter studies,13"14 tissue homogenization was performed in a hypotonic medium (10 mmol/L imidazole). Differences in osmolarity might affect the extent of SR disruption and the distribution of the ryanodine receptors among different subpopulations of SR vesicles, which is a major determinant of the effect of ryanodine on Ca 2 uptake (see below).
On the other hand, the results obtained in the PNS are consistent with a previous study performed in our laboratory, in which the response to ryanodine was found to be reduced after 10 minutes of ischemia.8 Such a reduction was greater than that observed in the present work, a possible explanation being the lower concentration of ryanodine (300 gmol/L) used in that study.
It is not easy to relate these data to the results of binding experiments. Assuming that preincubation with ryanodine determines full channel blockade,10'2 the response to ryanodine depends on many variables: the fraction of vesicles containing ryanodine receptors, the density of the receptors, channel conductivity and opening probability, and the rate of active Ca 2 transport.
Ryanodine binding is proportional to the number of channel molecules and also depends on their functional state. Comparative analysis of ryanodine binding and SR channel function after different interventions (changes in electrolyte and nucleotide concentrations, addition of benzimidazole or anthraquinone drugs, receptor phosphorylation by different kinases, and membrane exposure to oxygen radicals328,31324-44) suggests that reduced ryanodine binding is associated with reduced SR Ca2' efflux because of the reduced probability of channel opening or, more rarely, the reduced conductivity of the open channel. Therefore, whatever the mechanism responsible for decreased ryanodine binding may be, one should expect the response to ryanodine to be reduced in ischemic and reperfused hearts. We found that the stimulation of Ca 2 uptake produced by ryanodine was reduced in the PNS of ischemic hearts. However, the effect of ryanodine was nearly normal in unfractionated homogenate, in spite of a 25% to 30% reduction in ryanodine binding. In addition, active Ca 2 transport was impaired in ischemic hearts; this is another factor that could account for reduced pharmacologic response to ryanodine. Actually, the relative response to ryanodine (ie, this finding has been interpreted as evidence of increased Ca2+ channel conductivity.13 '14 Our results might be interpreted by the hypothesis that after ischemia the total number of ryanodinebinding channels is reduced but that the conductivity and/or opening probability of the remaining channels is increased. This hypothesis is highly speculative, since it is not clear what molecular mechanisms could support such effects. In addition, the conditions in which we determined Ca'+ uptake should produce maximum channel activation,336 and to our knowledge, states of supernormal conductivity have never been observed.
An alternative explanation is based on the observation that vesicles containing Ca'+ channels cannot accumulate Ca2' unless ryanodine or other channel blockers are present.1"12 These findings were obtained in the purified dog SR and still need validation in crude preparations, but they suggest that the most important variable that determines the response to ryanodine is the fraction of vesicles that contain ryanodine receptors.
There is no evidence that this variable is directly proportional to the overall number of receptor molecules. If most ryanodine-sensitive vesicles contain many Ca2' channels, significant reduction in ryanodine binding might occur without major changes in the number of channel-containing vesicles and hence in the effect of channel blockade on Ca21 uptake. In addition, it must be stressed that SR vesicles do not exist in vivo but are formed during tissue disruption, and it is likely that their size and content in membrane proteins depend critically on the physicochemical properties of the SR membrane and on the homogenization procedure. Ischemia-induced changes in membrane properties might therefore modify receptor distribution among vesicles independent from any direct effect on the receptor itself. As mentioned above, differences in homogenization technique might also be responsible for the different results obtained in Ca2+-uptake studies. 8"13-15 To test this hypothesis and to overcome the complications associated with SR fragmentation, intact SR should be studied. Recently, evaluation of intact SR function was performed in skinned cardiomyocytes.45 In this model, the stimulation of SR Ca21 uptake produced by inhibitors of SR Ca2' efflux at pCa <6 was reduced after simulated ischemia and reperfusion (see Fig 4 of Reference 45), a finding that is consistent with reduced density of active Ca21 channels.
In conclusion, our chief finding was that ischemia produced a reduction in the number of cardiac ryanodine receptors. Such a result is likely to imply that the number of channels available for Ca2' release is reduced, although the latter statement requires further experimental confirmation.
It is rather difficult to outline the pathophysiological implication of our findings, because in vivo SR Ca21 release is largely dependent on variables that cannot be assessed in vitro, such as phasic changes in cytosolic Ca21 concentration. As a working hypothesis, we suggest that the reduction in the number of active SR channels might be involved in the decreased Ca21 availability, which is thought to characterize the late phase of stunning.46'47 In view of the role of cytosolic Ca 2+ overload in the pathogenesis of irreversible tissue the ratio of Ca2+ uptake in the presence of ryanodine and basal Ca 2+ uptake) was increased after ischemia; injury, this phenomenon could also be related to ischemic preconditioning, ie, to the reduced susceptibility of the postischemic myocardium to further ischemic injury.48
